Cellink, a Swedish 3D Printing Company founded by Erik Gatenholm and Hector Martinez Avila, has announced their partnership with CTI Biotech, a French company based in Lyon, to fabricate tumors that can be used for pharmaceuticals testing. The ability to mix their own inks with cells from patients’ cancers will allow them to produce tumors that can be subjected to intense research without endangering human lives and simultaneously remove animal testing.

Dr. Pardraig Strappe, a microbiologist in central Queensland along with a team of researchers at CQUniversity, is using 3D printing, human stem cells, and crocodile cartilage to develop a 3D Printed Joint Cartilage to treat arthritis and joint injuries. The process involves extracting growth factors from crocodile cartilage, removing the proteins that set off a human immune response and adding adult stem cells using CELLINK 3D bioprinter.